Ian Collins
Affiliations: | The Institute of Cancer Research |
Google:
"Ian Collins"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Saint-Dizier F, Matthews TP, Gregson AM, et al. (2023) Discovery of 2-(3-Benzamidopropanamido)thiazole-5-carboxylate Inhibitors of the Kinesin HSET (KIFC1) and the Development of Cellular Target Engagement Probes. Journal of Medicinal Chemistry |
Miller DSJ, Voell SA, Sosič I, et al. (2022) Encoding BRAF inhibitor functions in protein degraders. Rsc Medicinal Chemistry. 13: 731-736 |
Pal A, Asad Y, Ruddle R, et al. (2020) Metabolomic changes of the multi (-AGC-) kinase inhibitor AT13148 in cells, mice and patients are associated with NOS regulation. Metabolomics : Official Journal of the Metabolomic Society. 16: 50 |
Rogers RF, Walton MI, Cherry DL, et al. (2020) CHK1 inhibition is synthetically lethal with loss of B-family DNA polymerase function in human lung and colorectal cancer cells. Cancer Research |
Pollock K, Liu M, Zaleska M, et al. (2019) Fragment-based screening identifies molecules targeting the substrate-binding ankyrin repeat domains of tankyrase. Scientific Reports. 9: 19130 |
Prevet H, Collins I. (2019) Labelled chemical probes for demonstrating direct target engagement in living systems. Future Medicinal Chemistry. 11: 1195-1224 |
Chopra R, Sadok A, Collins I. (2019) A critical evaluation of the approaches to targeted protein degradation for drug discovery. Drug Discovery Today. Technologies. 31: 5-13 |
Zaleska M, Pollock K, Collins I, et al. (2019) Solution NMR assignment of the ARC4 domain of human tankyrase 2. Biomolecular Nmr Assignments |
Colombano G, Caldwell JJ, Matthews TP, et al. (2019) Binding to an unusual inactive kinase conformation by highly selective inhibitors of inositol-requiring enzyme 1α kinase-endoribonuclease. Journal of Medicinal Chemistry |
Sharp SY, Chessum NE, Caldwell JJ, et al. (2018) Abstract 2976: Confirmation of in-cell target engagement using the proteolysis targeting chimeras (PROTACs) against pirin Cancer Research. 78: 2976-2976 |